10-Q Filing

BIO-PATH HOLDINGS, INC. CIK: 1133818 Q2 2025

Filing Information

Form Type	10-Q
Accession Number	`0001558370-25-011591`
Period End Date	20250630
Filing Date	20250814
Fiscal Year	2025
Fiscal Period	Q2
XBRL Instance	bpth-20250630x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 124 Income Statement 94 Cash Flow Statement 78 Stockholders Equity 46

Balance Sheet 124 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.01M	USD	Point-in-time
Cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.01M	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.05M	USD	Point-in-time
Cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.05M	USD	Point-in-time
Cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.17M	USD	Point-in-time
Cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.17M	USD	Point-in-time
Cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
Cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid drug product	`PrepaidExpenseCurrent`	$474.00K	USD	Point-in-time
Prepaid drug product	`PrepaidExpenseCurrent`	$474.00K	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid drug product	`PrepaidExpenseCurrent`	$1.07M	USD	Point-in-time
Prepaid drug product	`PrepaidExpenseCurrent`	$1.07M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.53M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.53M	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$206.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$206.00K	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$680.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$680.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.78M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.78M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	8.31M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	8.31M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	5.77M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	5.77M	shares	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$1.08M	USD	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$1.08M	USD	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$1.01M	USD	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$1.01M	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	5.77M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	5.77M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	8.31M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	8.31M	shares	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$1.00M	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$1.00M	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$1.05M	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$1.05M	USD	Point-in-time
Fixed assets, net	`PropertyPlantAndEquipmentNet`	$23.00K	USD	Point-in-time
Fixed assets, net	`PropertyPlantAndEquipmentNet`	$23.00K	USD	Point-in-time
Fixed assets, net	`PropertyPlantAndEquipmentNet`	$9.00K	USD	Point-in-time
Fixed assets, net	`PropertyPlantAndEquipmentNet`	$9.00K	USD	Point-in-time
Right of use operating assets	`OperatingLeaseRightOfUseAsset`	$57.00K	USD	Point-in-time
Right of use operating assets	`OperatingLeaseRightOfUseAsset`	$57.00K	USD	Point-in-time
Right of use operating assets	`OperatingLeaseRightOfUseAsset`	$84.00K	USD	Point-in-time
Right of use operating assets	`OperatingLeaseRightOfUseAsset`	$84.00K	USD	Point-in-time
Total Assets	`Assets`	$746.00K	USD	Point-in-time
Total Assets	`Assets`	$746.00K	USD	Point-in-time
Total Assets	`Assets`	$3.88M	USD	Point-in-time
Total Assets	`Assets`	$3.88M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.48M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.48M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.27M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.27M	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$422.00K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$422.00K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	-	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	-	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.94M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.94M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$3.91M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$3.91M	USD	Point-in-time
Lease liabilities	`OperatingLeaseLiabilityCurrent`	$83.00K	USD	Point-in-time
Lease liabilities	`OperatingLeaseLiabilityCurrent`	$83.00K	USD	Point-in-time
Lease liabilities	`OperatingLeaseLiabilityCurrent`	$57.00K	USD	Point-in-time
Lease liabilities	`OperatingLeaseLiabilityCurrent`	$57.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$7.86M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$7.86M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.29M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.29M	USD	Point-in-time
Warrant liability	`WarrantsAndRightsOutstanding`	$434.00K	USD	Point-in-time
Warrant liability	`WarrantsAndRightsOutstanding`	$434.00K	USD	Point-in-time
Warrant liability	`WarrantsAndRightsOutstanding`	$40.00K	USD	Point-in-time
Warrant liability	`WarrantsAndRightsOutstanding`	$40.00K	USD	Point-in-time
Total Liabilities	`Liabilities`	$3.73M	USD	Point-in-time
Total Liabilities	`Liabilities`	$3.73M	USD	Point-in-time
Total Liabilities	`Liabilities`	$7.90M	USD	Point-in-time
Total Liabilities	`Liabilities`	$7.90M	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 8,308 and 5,768 shares issued and outstanding, respectively	`CommonStockValue`	$8.00K	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 8,308 and 5,768 shares issued and outstanding, respectively	`CommonStockValue`	$8.00K	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 8,308 and 5,768 shares issued and outstanding, respectively	`CommonStockValue`	$6.00K	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 8,308 and 5,768 shares issued and outstanding, respectively	`CommonStockValue`	$6.00K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$117.78M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$117.78M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$117.65M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$117.65M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-117.50M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-117.50M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-124.95M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-124.95M	USD	Point-in-time
Total shareholders' (deficit) equity	`StockholdersEquity`	$154.00K	USD	Point-in-time
Total shareholders' (deficit) equity	`StockholdersEquity`	$154.00K	USD	Point-in-time
Total shareholders' (deficit) equity	`StockholdersEquity`	$-7.16M	USD	Point-in-time
Total shareholders' (deficit) equity	`StockholdersEquity`	$-7.16M	USD	Point-in-time
Total Liabilities & Shareholders' (Deficit) Equity	`LiabilitiesAndStockholdersEquity`	$746.00K	USD	Point-in-time
Total Liabilities & Shareholders' (Deficit) Equity	`LiabilitiesAndStockholdersEquity`	$746.00K	USD	Point-in-time
Total Liabilities & Shareholders' (Deficit) Equity	`LiabilitiesAndStockholdersEquity`	$3.88M	USD	Point-in-time
Total Liabilities & Shareholders' (Deficit) Equity	`LiabilitiesAndStockholdersEquity`	$3.88M	USD	Point-in-time

Income Statement 94 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$4.05M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.05M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.87M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.87M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.16M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$4.16M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$6.03M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$6.03M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$2.57M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$2.57M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.78M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.78M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$514.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$514.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.17M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.17M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$7.80M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$7.80M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$6.73M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$6.73M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$4.56M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$4.56M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$3.04M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$3.04M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-6.73M	USD	2 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-6.73M	USD	2 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-4.56M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-4.56M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-3.04M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-3.04M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-7.80M	USD	2 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-7.80M	USD	2 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-1.70M	USD	2 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-1.70M	USD	2 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-1.16M	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-1.16M	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-394.00K	USD	2 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-394.00K	USD	2 Qtrs
Interest expense	`InterestExpenseDebt`	$35.00K	USD	1 Quarter
Interest expense	`InterestExpenseDebt`	$35.00K	USD	1 Quarter
Interest expense	`InterestExpenseDebt`	$40.00K	USD	2 Qtrs
Interest expense	`InterestExpenseDebt`	$40.00K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$6.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$6.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$6.00K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$6.00K	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$1.17M	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$1.17M	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$1.71M	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$1.71M	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$354.00K	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$354.00K	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$-35.00K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-35.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.45M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-7.45M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-4.60M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.60M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.87M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.87M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.03M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-5.03M	USD	2 Qtrs
Net loss per share, basic	`EarningsPerShareBasic`	$-1.16	USD	1 Quarter
Net loss per share, basic	`EarningsPerShareBasic`	$-1.16	USD	1 Quarter
Net loss per share, basic	`EarningsPerShareBasic`	$-4.45	USD	2 Qtrs
Net loss per share, basic	`EarningsPerShareBasic`	$-4.45	USD	2 Qtrs
Net loss per share, basic	`EarningsPerShareBasic`	$-0.55	USD	1 Quarter
Net loss per share, basic	`EarningsPerShareBasic`	$-0.55	USD	1 Quarter
Net loss per share, basic	`EarningsPerShareBasic`	$-0.97	USD	2 Qtrs
Net loss per share, basic	`EarningsPerShareBasic`	$-0.97	USD	2 Qtrs
Weighted average number of common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	1.61M	shares	1 Quarter
Weighted average number of common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	1.61M	shares	1 Quarter
Weighted average number of common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	7.69M	shares	2 Qtrs
Weighted average number of common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	7.69M	shares	2 Qtrs
Weighted average number of common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	8.31M	shares	1 Quarter
Weighted average number of common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	8.31M	shares	1 Quarter
Weighted average number of common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	1.13M	shares	2 Qtrs
Weighted average number of common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	1.13M	shares	2 Qtrs
Net loss per share, diluted	`EarningsPerShareDiluted`	$-1.16	USD	1 Quarter
Net loss per share, diluted	`EarningsPerShareDiluted`	$-1.16	USD	1 Quarter
Net loss per share, diluted	`EarningsPerShareDiluted`	$-0.55	USD	1 Quarter
Net loss per share, diluted	`EarningsPerShareDiluted`	$-0.55	USD	1 Quarter
Net loss per share, diluted	`EarningsPerShareDiluted`	$-4.45	USD	2 Qtrs
Net loss per share, diluted	`EarningsPerShareDiluted`	$-4.45	USD	2 Qtrs
Net loss per share, diluted	`EarningsPerShareDiluted`	$-0.97	USD	2 Qtrs
Net loss per share, diluted	`EarningsPerShareDiluted`	$-0.97	USD	2 Qtrs
Weighted average number of common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	8.31M	shares	1 Quarter
Weighted average number of common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	8.31M	shares	1 Quarter
Weighted average number of common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	7.69M	shares	2 Qtrs
Weighted average number of common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	7.69M	shares	2 Qtrs
Weighted average number of common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.13M	shares	2 Qtrs
Weighted average number of common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.13M	shares	2 Qtrs
Weighted average number of common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.61M	shares	1 Quarter
Weighted average number of common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.61M	shares	1 Quarter

Cash Flow Statement 78 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-5.03M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-5.03M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-7.45M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-7.45M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$311.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$311.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$136.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$136.00K	USD	2 Qtrs
Amortization of debt issuance costs	`AmortizationOfDeferredCharges`	$40.00K	USD	2 Qtrs
Amortization of debt issuance costs	`AmortizationOfDeferredCharges`	$40.00K	USD	2 Qtrs
Amortization of right of use assets	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$59.00K	USD	2 Qtrs
Amortization of right of use assets	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$59.00K	USD	2 Qtrs
Amortization of right of use assets	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$51.00K	USD	2 Qtrs
Amortization of right of use assets	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$51.00K	USD	2 Qtrs
Depreciation	`Depreciation`	$14.00K	USD	2 Qtrs
Depreciation	`Depreciation`	$14.00K	USD	2 Qtrs
Depreciation	`Depreciation`	$28.00K	USD	2 Qtrs
Depreciation	`Depreciation`	$28.00K	USD	2 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-1.70M	USD	2 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-1.70M	USD	2 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-1.16M	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-1.16M	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-394.00K	USD	2 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-394.00K	USD	2 Qtrs
Prepaid drug product	`IncreaseDecreaseInPrepaidExpense`	$-600.00K	USD	2 Qtrs
Prepaid drug product	`IncreaseDecreaseInPrepaidExpense`	$-600.00K	USD	2 Qtrs
Prepaid drug product	`IncreaseDecreaseInPrepaidExpense`	$-358.00K	USD	2 Qtrs
Prepaid drug product	`IncreaseDecreaseInPrepaidExpense`	$-358.00K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-1.28M	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-1.28M	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-619.00K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-619.00K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$4.12M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$4.12M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.15M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.15M	USD	2 Qtrs
Interest payable	`IncreaseDecreaseInInterestPayableNet`	$51.00K	USD	2 Qtrs
Interest payable	`IncreaseDecreaseInInterestPayableNet`	$51.00K	USD	2 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-58.00K	USD	2 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-58.00K	USD	2 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-58.00K	USD	2 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-58.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.60M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.60M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.27M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.27M	USD	2 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$7.22M	USD	2 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$7.22M	USD	2 Qtrs
Net proceeds from exercise of pre-funded warrants	`ProceedsFromWarrantExercises`	$1.00K	USD	2 Qtrs
Net proceeds from exercise of pre-funded warrants	`ProceedsFromWarrantExercises`	$1.00K	USD	2 Qtrs
Proceeds from promissory notes	`ProceedsFromNotesPayable`	$422.00K	USD	2 Qtrs
Proceeds from promissory notes	`ProceedsFromNotesPayable`	$422.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$423.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$423.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$7.22M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$7.22M	USD	2 Qtrs
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$2.95M	USD	2 Qtrs
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$2.95M	USD	2 Qtrs
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.17M	USD	2 Qtrs
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.17M	USD	2 Qtrs
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.01M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.01M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.05M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.05M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.17M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.17M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.01M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.01M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.05M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.05M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.17M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.17M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
Right of use asset recognized in exchange for lease obligation	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$32.00K	USD	2 Qtrs
Right of use asset recognized in exchange for lease obligation	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$32.00K	USD	2 Qtrs

Stockholders Equity 46 line items

Line Item	Tag	Value	Unit	Period
Stockholders' equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.29M	USD	Point-in-time
Stockholders' equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.29M	USD	Point-in-time
Stockholders' equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$441.00K	USD	Point-in-time
Stockholders' equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$441.00K	USD	Point-in-time
Stockholders' equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.59M	USD	Point-in-time
Stockholders' equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.59M	USD	Point-in-time
Stockholders' equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$154.00K	USD	Point-in-time
Stockholders' equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$154.00K	USD	Point-in-time
Stockholders' equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-7.16M	USD	Point-in-time
Stockholders' equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-7.16M	USD	Point-in-time
Stockholders' equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.62M	USD	Point-in-time
Stockholders' equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.62M	USD	Point-in-time
Issuance of common stock and warrants, net of fees and warrant liability	`StockIssuedDuringPeriodValueNewIssues`	$5.64M	USD	1 Quarter
Issuance of common stock and warrants, net of fees and warrant liability	`StockIssuedDuringPeriodValueNewIssues`	$5.64M	USD	1 Quarter
Issuance of common stock and warrants, net of fees and warrant liability	`StockIssuedDuringPeriodValueNewIssues`	$5.57M	USD	2 Qtrs
Issuance of common stock and warrants, net of fees and warrant liability	`StockIssuedDuringPeriodValueNewIssues`	$5.57M	USD	2 Qtrs
Exercise of pre-funded warrants, net of fees	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$1.00K	USD	2 Qtrs
Exercise of pre-funded warrants, net of fees	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$1.00K	USD	2 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$136.00K	USD	2 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$136.00K	USD	2 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$141.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$141.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$311.00K	USD	2 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$311.00K	USD	2 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$28.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$28.00K	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$-7.45M	USD	2 Qtrs
Net Income (Loss)	`NetIncomeLoss`	$-7.45M	USD	2 Qtrs
Net Income (Loss)	`NetIncomeLoss`	$-4.60M	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$-4.60M	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$-1.87M	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$-1.87M	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$-5.03M	USD	2 Qtrs
Net Income (Loss)	`NetIncomeLoss`	$-5.03M	USD	2 Qtrs
Stockholders' equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.29M	USD	Point-in-time
Stockholders' equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.29M	USD	Point-in-time
Stockholders' equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$441.00K	USD	Point-in-time
Stockholders' equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$441.00K	USD	Point-in-time
Stockholders' equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.59M	USD	Point-in-time
Stockholders' equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.59M	USD	Point-in-time
Stockholders' equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$154.00K	USD	Point-in-time
Stockholders' equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$154.00K	USD	Point-in-time
Stockholders' equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-7.16M	USD	Point-in-time
Stockholders' equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-7.16M	USD	Point-in-time
Stockholders' equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.62M	USD	Point-in-time
Stockholders' equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.62M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.